ACTRN12605000638639
Completed
Not Applicable
Post acute rehabilitation: A randomised controlled trial of day hospital and domiciliary care versus Rehabilitation in the Home for deconditioned patients following hospitalisation to improve functional and nutritional status.
Professor Maria Crotty0 sites140 target enrollmentOctober 13, 2005
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Professor Maria Crotty
- Enrollment
- 140
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with either neurological injury, orthopaedic injury, or other medical condition requiring rehabilitation, medically stable, safe and appropriate to return home, requires at least 12 sessions of rehabilitation, sufficient memory and reasoning to participate in rehabilitation, has access to and is able to a use telephone, able to travel in a car for up to one hours two times per day.
Exclusion Criteria
- •If consultant physician decided that RITHOM is definately indicated or Day Hospital is definately contraindicated.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
To study the effectiveness of pulmonary rehabilitation program in people who have recovered from covid 19 pneumonia and Acute Respiratory DistressHealth Condition 1: F- Physical Rehabilitation and Diagnostic AudiologyCTRI/2020/12/029957Department of PMR
Completed
Not Applicable
The effectiveness of rehabilitation after surgical treatment of trigger fingerJPRN-UMIN000036137Okayama university60
Unknown
Phase 3
A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of UFT Compared With Surgery Alone for Serosa-negative Advanced Gastric Cancer (NSAS-GC).Gastric cancerJPRN-jRCT1080220057Taiho Pharmaceutical Co., Ltd.
Unknown
Phase 3
A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC).Bowel cancerJPRN-jRCT1080220056Taiho Pharmaceutical Co., Ltd.
Unknown
Phase 3
A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC).Breast canerJPRN-jRCT1080220055Taiho Pharmaceutical Co., Ltd.